{
    "root": "30a06de6-ded3-748c-e063-6294a90afb0f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metoprolol Tartrate",
    "value": "20250318",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "METOPROLOL TARTRATE",
            "code": "W5S57Y3A5L"
        },
        {
            "name": "D&C RED NO. 30",
            "code": "2S42T2808B"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        }
    ],
    "indications": "metoprolol tartrate tablets beta-adrenergic blocker indicated treatment : hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) angina pectoris . ( 1.2 ) myocardial infarction , reduce risk cardiovascular mortality used conjunction intravenous metoprolol therapy patients definite suspected acute myocardial infarction hemodynamically stable patients . ( 1.3 )",
    "contraindications": "administer daily food meal . titrate weekly longer intervals needed tolerated . ( 2 ) hypertension : recommended starting 100 mg daily , single divided doses . ( 2.1 ) angina pectoris : recommended starting 100 mg daily , given two divided doses . ( 2.2 ) myocardial infarction : starting depends upon tolerance intravenous metoprolol , full prescribing information . ( 2.3 )",
    "warningsAndPrecautions": "metoprolol tartrate tablets , usp available follows : tablets 25 mg white round shaped , film coated tablets debossed ‘ c 73 ’ one side deep break line side . bottles 20 ndc 76420-054-20 ( repackaged ndc 57237-100-xx ) bottles 30 ndc 76420-054-30 ( repackaged ndc 57237-100-xx ) bottles 60 ndc 76420-054-60 ( repackaged ndc 57237-100-xx ) bottles 90 ndc 76420-054-90 ( repackaged ndc 57237-100-xx ) bottles 100 ndc 76420-054-01 ( relabeled ndc 57237-100-01 ) bottles 1,000 ndc 76420-054-00 ( relabeled ndc 57237-100-99 ) tablets 50 mg pink round shaped , film coated tablets debossed ‘ c 74 ’ one side deep break line side . bottles 20 ndc 76420-953-20 ( repackaged ndc 57237-101-xx ) bottles 30 ndc 76420-953-30 ( repackaged ndc 57237-101-xx ) bottles 60 ndc 76420-953-60 ( repackaged ndc 57237-101-xx ) bottles 90 ndc 76420-953-90 ( repackaged ndc 57237-101-xx ) bottles 100 ndc 76420-953-01 ( relabeled ndc 57237-101-01 ) bottles 1,000 ndc 76420-953-00 ( relabeled ndc 57237-101-99 ) tablets 100 mg light blue round shaped , film coated tablets debossed ‘ c 75 ’ one side deep break line side . bottles 20 ndc 76420-954-20 ( repackaged ndc 57237-102-xx ) bottles 30 ndc 76420-954-30 ( repackaged ndc 57237-102-xx ) bottles 60 ndc 76420-954-60 ( repackaged ndc 57237-102-xx ) bottles 90 ndc 76420-954-90 ( repackaged ndc 57237-102-xx ) bottles 100 ndc 76420-954-01 ( relabeled ndc 57237-102-01 ) bottles 1,000 ndc 76420-954-00 ( relabeled ndc 57237-102-99 ) store 20° 25 °c ( 68° 77 °f ) ; excursions permitted 15 ° 30 °c ( 59 ° 86 °f ) [ usp controlled room temperature ] . protect moisture heat . dispensein tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "metoprolol tartrate tablets contraindicated severe bradycardia , second- third-degree heart block , cardiogenic shock , systolic blood pressure < 100 , decompensated heart failure , sick sinus syndrome ( unless permanent pacemaker place ) , patients hypersensitive component product .",
    "indications_original": "Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. ( 1.3 )",
    "contraindications_original": "Administer once daily with food or after a meal. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) Hypertension: Recommended starting dosage is 100 mg daily, in single or divided doses. ( 2.1 ) Angina Pectoris: Recommended starting dosage is 100 mg daily, given as two divided doses. ( 2.2 ) Myocardial Infarction: The starting dosage depends upon tolerance of intravenous metoprolol, see full prescribing information. ( 2.3 )",
    "warningsAndPrecautions_original": "Metoprolol Tartrate Tablets, USP are available as follows:\n                  \n                  \n                     \n                        Tablets 25 mg\n                     are white round shaped, film coated tablets debossed with ‘C over 73’ on one side and deep break line on other side.\n\n \n                  Bottles of 20 NDC 76420-054-20 (repackaged from NDC 57237-100-xx)\n                  Bottles of 30 NDC 76420-054-30 (repackaged from NDC 57237-100-xx)\n                  Bottles of 60 NDC 76420-054-60 (repackaged from NDC 57237-100-xx)\n                  Bottles of 90 NDC 76420-054-90 (repackaged from NDC 57237-100-xx)\n                  Bottles of 100 NDC 76420-054-01 (relabeled from NDC 57237-100-01)\n                  Bottles of 1,000 NDC 76420-054-00 (relabeled from NDC 57237-100-99)\n                  \n                  \n                     \n                        Tablets 50 mg\n                     are pink round shaped, film coated tablets debossed with ‘C over 74’ on one side and deep break line on other side.\n\n \n                  Bottles of 20 NDC 76420-953-20 (repackaged from NDC 57237-101-xx)\n                  Bottles of 30 NDC 76420-953-30 (repackaged from NDC 57237-101-xx)\n                  Bottles of 60 NDC 76420-953-60 (repackaged from NDC 57237-101-xx)\n                  Bottles of 90 NDC 76420-953-90 (repackaged from NDC 57237-101-xx)\n                  Bottles of 100 NDC 76420-953-01 (relabeled from NDC 57237-101-01)\n                  Bottles of 1,000 NDC 76420-953-00 (relabeled from NDC 57237-101-99)\n                  \n                  \n                     \n                        Tablets 100 mg\n                     are light blue round shaped, film coated tablets debossed with ‘C over 75’ on one side and deep break line on other side.\n\n \n                  Bottles of 20 NDC 76420-954-20 (repackaged from NDC 57237-102-xx)\n                  Bottles of 30 NDC 76420-954-30 (repackaged from NDC 57237-102-xx)\n                  Bottles of 60 NDC 76420-954-60 (repackaged from NDC 57237-102-xx)\n                  Bottles of 90 NDC 76420-954-90 (repackaged from NDC 57237-102-xx)\n                  Bottles of 100 NDC 76420-954-01 (relabeled from NDC 57237-102-01)\n                  Bottles of 1,000 NDC 76420-954-00 (relabeled from NDC 57237-102-99)\n                  \n                  \n                     Store at 20° to 25\n                     °C (68° to 77\n                     °F); excursions permitted to 15\n                     ° to 30\n                     °C (59\n                     ° to 86\n                     °F)\n                     [see USP Controlled Room Temperature\n                     ].\n                  \n                  \n                  \n                     Protect from moisture and heat.\n                  \n                  \n                     Dispensein a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Metoprolol tartrate tablets are contraindicated in severe bradycardia, second- or third-degree heart block, cardiogenic shock, systolic blood pressure <100, decompensated heart failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product."
}